CVS Health (CVS) closed at $93.47 on October 23, 2026, down 1.1% from the previous close, on volume of 3,305,788 shares (30-day average 8,785,317).
Data as of October 23, 2026.
CVS Caremark, Express Scripts, Optum Rx targeted in House investigation
Seeking Alpha News (Fri, 23-Oct 12:14 PM ET)
CVS Pharmacy expands fall assortment of collectibles, nostalgic favorites and seasonal exclusives
PRNewswire (Fri, 23-Oct 9:01 AM ET)
Centene, Harmony Biosciences lead list of undervalued healthcare stocks
Seeking Alpha News (Thu, 22-Oct 9:45 AM ET)
MinuteClinic opens three new retail medical clinics to serve Massachusetts patients
PRNewswire (Tue, 20-Oct 9:01 AM ET)
The Future of Healthcare: AI-Powered, Coordinated and Proactive Care
Globe Newswire (Mon, 19-Oct 8:30 AM ET)
Goldman's defensive stocks with quality-growth characteristics
Seeking Alpha News (Sun, 18-Oct 11:04 AM ET)
Notable healthcare headlines for the week: J&J, UnitedHealth, and CVS in focus
Seeking Alpha News (Sun, 18-Oct 9:05 AM ET)
The Week That Was, The Week Ahead: Macro and Markets, October 18
TipRanks (Sun, 18-Oct 4:28 AM ET)
Market Chameleon (Thu, 15-Oct 5:20 AM ET)
CVS Health collaborates with The Midlife Collective to redefine a woman's midlife health journey
PRNewswire (Thu, 15-Oct 9:01 AM ET)
CVS Health offers a diverse set of healthcare services. Its roots are in its retail pharmacy operations, where it operates around 9,000 stores primarily in the US. CVS is also a large pharmacy benefit manager (acquired through Caremark), processing about 2 billion adjusted claims annually. It operates a top-tier health insurer (acquired through Aetna) through which it serves about 26 million medical members. The acquisition of Oak Street Health added primary care services to the mix, which could have significant synergies with all existing business lines.
CVS Health trades on the NYSE stock market under the symbol CVS.
As of October 23, 2026, CVS stock price declined to $93.47 with 3,305,788 million shares trading.
CVS has a beta of 0.10, meaning it tends to be less sensitive to market movements. CVS has a correlation of 0.00 to the broad based SPY ETF.
CVS has a market cap of $118.91 billion. This is considered a Large Cap stock.
Last quarter CVS Health reported $106 billion in Revenue and $2.58 earnings per share. This beat revenue expectation by $6 billion and exceeded earnings estimates by $.74.
In the last 3 years, CVS traded as high as $110.68 and as low as $43.56.
The top ETF exchange traded funds that CVS belongs to (by Net Assets): VTI, VOO, IVV, SPY, VTV.
CVS has outperformed the market in the last year with a price return of +19.0% while the SPY ETF gained +14.9%. However, in the short term, CVS had mixed performance relative to the market. It has underperformed in the last 3 months, returning -11.7% vs +1.9% return in SPY. But in the last 2 weeks, CVS shares have fared better than the market returning +7.2% compared to SPY -1.8%.
CVS support price is $92.74 and resistance is $96.22 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CVS shares will trade within this expected range on the day.
